50-198-5063
Vitamin D Receptor/VDR Rabbit anti-Human, Polyclonal, Bioss
Manufacturer: Bioss
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | 50-198-5063-Each-of-1 | In Stock | ₹ 36,897.75 |
50-198-5063 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 36,897.75
GST (18%): ₹ 6,641.595
Total Price: ₹ 43,539.345
Antigen
Vitamin D Receptor/VDR
Classification
Polyclonal
Conjugate
Unconjugated
Gene
VDR
Gene Alias
1,25-dihydroxyvitamin D3 receptor; HGNC:12679; I79_025795; NR1I1; Nuclear receptor subfamily 1 group I member 1; PPP1R163; protein phosphatase 1, regulatory subunit 163; Vdr; vitamin D (1,25- dihydroxyvitamin D3) receptor; vitamin D (1,25-dihydroxyvitamin D3) receptor; vitamin D nuclear receptor variant 1; vitamin D receptor; Vitamin D3 receptor
Host Species
Rabbit
Purification Method
Protein A
Regulatory Status
RUO
Gene ID (Entrez)
7421
Content And Storage
-20°C
Form
Liquid
Applications
Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot
Concentration
1 μg/mL
Formulation
PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH
Gene Accession No.
P11473
Gene Symbols
VDR
Immunogen
KLH conjugated synthetic peptide derived from human Vitamin D Receptor .
Quantity
100 μL
Primary or Secondary
Primary
Target Species
Human
Product Type
Antibody
Isotype
IgG
Related Products
Description
- Steroid receptors are ligand-dependent intracellular proteins that stimulate transcription of specific genes by binding to specific DNA sequences following activation by the appropriate hormone
- The 1,25-dihydroxy-vitamin D3 receptor (VDR) belongs to the superfamily of steroid hormone receptors which includes estrogen, progesterone, glucocorticoid, androgen, and thyroid hormone receptors
- Vitamin D modulates calcium and phosphorus homeostasis, bone remodeling, cell growth regulation, and differentiation
- Studies have found VDR in the intestine, bone, kidney, epidermis, and cells of the endocrine immune system
- Repression of T-cell proliferation and interleukin-2 (IL-2) gene expression, for example, occurs when VDR binds within the IL-2 enhancer
- Formation of VDR/retinoic X receptor (RXR) heterodimers in the presence of intracellular 1,25(OH)2D3 has been shown to interfere with assembly of nuclear factor of activated T-cells (NFATp)/Fos/Jun/DNA complex and subsequent IL-2 gene transcription
- The corresponding gene for the vitamin D receptor is NR1I1.
Compare Similar Items
Show Difference
Antigen: Vitamin D Receptor/VDR
Classification: Polyclonal
Conjugate: Unconjugated
Gene: VDR
Gene Alias: 1,25-dihydroxyvitamin D3 receptor; HGNC:12679; I79_025795; NR1I1; Nuclear receptor subfamily 1 group I member 1; PPP1R163; protein phosphatase 1, regulatory subunit 163; Vdr; vitamin D (1,25- dihydroxyvitamin D3) receptor; vitamin D (1,25-dihydroxyvitamin D3) receptor; vitamin D nuclear receptor variant 1; vitamin D receptor; Vitamin D3 receptor
Host Species: Rabbit
Purification Method: Protein A
Regulatory Status: RUO
Gene ID (Entrez): 7421
Content And Storage: -20°C
Form: Liquid
Applications: Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot
Concentration: 1 μg/mL
Formulation: PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH
Gene Accession No.: P11473
Gene Symbols: VDR
Immunogen: KLH conjugated synthetic peptide derived from human Vitamin D Receptor .
Quantity: 100 μL
Primary or Secondary: Primary
Target Species: Human
Product Type: Antibody
Isotype: IgG
Antigen:
Vitamin D Receptor/VDR
Classification:
Polyclonal
Conjugate:
Unconjugated
Gene:
VDR
Gene Alias:
1,25-dihydroxyvitamin D3 receptor; HGNC:12679; I79_025795; NR1I1; Nuclear receptor subfamily 1 group I member 1; PPP1R163; protein phosphatase 1, regulatory subunit 163; Vdr; vitamin D (1,25- dihydroxyvitamin D3) receptor; vitamin D (1,25-dihydroxyvitamin D3) receptor; vitamin D nuclear receptor variant 1; vitamin D receptor; Vitamin D3 receptor
Host Species:
Rabbit
Purification Method:
Protein A
Regulatory Status:
RUO
Gene ID (Entrez):
7421
Content And Storage:
-20°C
Form:
Liquid
Applications:
Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot
Concentration:
1 μg/mL
Formulation:
PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH
Gene Accession No.:
P11473
Gene Symbols:
VDR
Immunogen:
KLH conjugated synthetic peptide derived from human Vitamin D Receptor .
Quantity:
100 μL
Primary or Secondary:
Primary
Target Species:
Human
Product Type:
Antibody
Isotype:
IgG
Antigen: Mitofusin 2
Classification: Polyclonal
Conjugate: Unconjugated
Gene: MFN2
Gene Alias: BOS_15842; CMT2A; CMT2A2; CPRP 1; CPRP1; D630023P19Rik; Fzo; HMSN6A; HSG; HSG protein; hyperplasia suppressor; hypertension related protein 1; hypertension-related protein; Hypertension-related protein 1; Kiaa0214; Marf; MFN 2; Mfn2; mg:cb01g09; Mitochondrial assembly regulatory factor; mitochondrial transmembrane GTPase FZO1A; mitofusin 2; Mitofusin2; Mitofusin-2; si:dkeyp-104h9.2; Transmembrane GTPase MFN2; wu:fb79a11
Host Species: Rabbit
Purification Method: Protein A
Regulatory Status: RUO
Gene ID (Entrez): 9927
Content And Storage: -20°C
Form: Liquid
Applications: Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot
Concentration: 1 μg/mL
Formulation: PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH
Gene Accession No.: O95140
Gene Symbols: MFN2
Immunogen: KLH conjugated synthetic peptide derived from human Mitofusin 2.
Quantity: 100 μL
Primary or Secondary: Primary
Target Species: Human
Product Type: Antibody
Isotype: IgG
Antigen:
Mitofusin 2
Classification:
Polyclonal
Conjugate:
Unconjugated
Gene:
MFN2
Gene Alias:
BOS_15842; CMT2A; CMT2A2; CPRP 1; CPRP1; D630023P19Rik; Fzo; HMSN6A; HSG; HSG protein; hyperplasia suppressor; hypertension related protein 1; hypertension-related protein; Hypertension-related protein 1; Kiaa0214; Marf; MFN 2; Mfn2; mg:cb01g09; Mitochondrial assembly regulatory factor; mitochondrial transmembrane GTPase FZO1A; mitofusin 2; Mitofusin2; Mitofusin-2; si:dkeyp-104h9.2; Transmembrane GTPase MFN2; wu:fb79a11
Host Species:
Rabbit
Purification Method:
Protein A
Regulatory Status:
RUO
Gene ID (Entrez):
9927
Content And Storage:
-20°C
Form:
Liquid
Applications:
Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot
Concentration:
1 μg/mL
Formulation:
PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH
Gene Accession No.:
O95140
Gene Symbols:
MFN2
Immunogen:
KLH conjugated synthetic peptide derived from human Mitofusin 2.
Quantity:
100 μL
Primary or Secondary:
Primary
Target Species:
Human
Product Type:
Antibody
Isotype:
IgG
Antigen: CITED1
Classification: Polyclonal
Conjugate: Unconjugated
Gene: CITED1
Gene Alias: AI316840; AU019144; BOS_25819; Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1; Cbp/p300-interacting transactivator 1; Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1; Cbp/p300-interacting transactivator, with Glu/Asp rich carboxy-terminal domain, 1; Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1; CITED1; LOC100356232; melanocyte-specific gene 1; melanocyte-specific gene 1 protein; Melanocyte-specific protein 1; MSG1; transactivator, with Glu/Asp-rich carboxy-terminal domain, 1
Host Species: Rabbit
Purification Method: Protein A
Regulatory Status: RUO
Gene ID (Entrez): 4435
Content And Storage: -20°C
Form: Liquid
Applications: Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot
Concentration: 1 μg/mL
Formulation: PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH
Gene Accession No.: Q99966
Gene Symbols: CITED1
Immunogen: KLH conjugated synthetic peptide derived from human CITED1.
Quantity: 100 μL
Primary or Secondary: Primary
Target Species: Human
Product Type: Antibody
Isotype: IgG
Antigen:
CITED1
Classification:
Polyclonal
Conjugate:
Unconjugated
Gene:
CITED1
Gene Alias:
AI316840; AU019144; BOS_25819; Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1; Cbp/p300-interacting transactivator 1; Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1; Cbp/p300-interacting transactivator, with Glu/Asp rich carboxy-terminal domain, 1; Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1; CITED1; LOC100356232; melanocyte-specific gene 1; melanocyte-specific gene 1 protein; Melanocyte-specific protein 1; MSG1; transactivator, with Glu/Asp-rich carboxy-terminal domain, 1
Host Species:
Rabbit
Purification Method:
Protein A
Regulatory Status:
RUO
Gene ID (Entrez):
4435
Content And Storage:
-20°C
Form:
Liquid
Applications:
Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot
Concentration:
1 μg/mL
Formulation:
PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH
Gene Accession No.:
Q99966
Gene Symbols:
CITED1
Immunogen:
KLH conjugated synthetic peptide derived from human CITED1.
Quantity:
100 μL
Primary or Secondary:
Primary
Target Species:
Human
Product Type:
Antibody
Isotype:
IgG
Antigen: CYP2D6
Classification: Polyclonal
Conjugate: Unconjugated
Gene: CYP2D6
Gene Alias: Cholesterol 25-hydroxylase; CPD6; CYP2D; Cyp2d13; Cyp2d18; Cyp2d-18; Cyp2d22; Cyp2d3; Cyp2d-3; Cyp2d4; Cyp2d-4; Cyp2d4v1; Cyp2d4v2; CYP2D6; CYP2D7AP; CYP2D7BP; CYP2D7P2; CYP2D8P2; CYP2DL1; CYPIID18; CYPIID3; CYPIID4; CYPIID6; Cytochrome P450 2D18; Cytochrome P450 2D-29; Cytochrome P450 2D3; Cytochrome P450 2D-35; Cytochrome P450 2D4; Cytochrome P450 2D6; cytochrome P450 family 2 subfamily D member 6; cytochrome P450, family 2, subfamily d, polypeptide 13; cytochrome P450, family 2, subfamily d, polypeptide 22; cytochrome P450, family 2, subfamily d, polypeptide 3; cytochrome P450, family 2, subfamily d, polypeptide 4; cytochrome P450, family 2, subfamily D, polypeptide 6; cytochrome P450, family 2, subfamily D, polypeptide 7 pseudogene 2; cytochrome P450, family 2, subfamily D, polypeptide 8 pseudogene 2; cytochrome P450, subfamily 2D, polypeptide 6; cytochrome P450, subfamily II (debrisoquine, sparteine, etc., -metabolising), polypeptide 7 pseudogene 2; cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolising), polypeptide 8 pseudogene 2; cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolizing), polypeptide 6; cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolizing)-like 1; cytochrome P450, subfamily IID, polypeptide 6; Cytochrome P450, subfamily IID3; Cytochrome P450, subfamily IID4; Cytochrome P450-CMF3; Cytochrome P450-DB1; Cytochrome P450-DB3; Cytochrome P450-DB4; Debrisoquine 4-hydroxylase; flavoprotein-linked monooxygenase; microsomal monooxygenase; nonfunctional cytochrome P450 2D6; P450 2D-29/2D-35; P450C2D; P450-CMF3; P450DB1; P450-DB1; P450-DB3; P450-DB4; xenobiotic monooxygenase
Host Species: Rabbit
Purification Method: Protein A
Regulatory Status: RUO
Gene ID (Entrez): 1565
Content And Storage: -20°C
Form: Liquid
Applications: Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot
Concentration: 1 μg/mL
Formulation: PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH
Gene Accession No.: P10635
Gene Symbols: CYP2D6
Immunogen: KLH conjugated synthetic peptide derived from human CYP2D6.
Quantity: 100 μL
Primary or Secondary: Primary
Target Species: Human
Product Type: Antibody
Isotype: IgG
Antigen:
CYP2D6
Classification:
Polyclonal
Conjugate:
Unconjugated
Gene:
CYP2D6
Gene Alias:
Cholesterol 25-hydroxylase; CPD6; CYP2D; Cyp2d13; Cyp2d18; Cyp2d-18; Cyp2d22; Cyp2d3; Cyp2d-3; Cyp2d4; Cyp2d-4; Cyp2d4v1; Cyp2d4v2; CYP2D6; CYP2D7AP; CYP2D7BP; CYP2D7P2; CYP2D8P2; CYP2DL1; CYPIID18; CYPIID3; CYPIID4; CYPIID6; Cytochrome P450 2D18; Cytochrome P450 2D-29; Cytochrome P450 2D3; Cytochrome P450 2D-35; Cytochrome P450 2D4; Cytochrome P450 2D6; cytochrome P450 family 2 subfamily D member 6; cytochrome P450, family 2, subfamily d, polypeptide 13; cytochrome P450, family 2, subfamily d, polypeptide 22; cytochrome P450, family 2, subfamily d, polypeptide 3; cytochrome P450, family 2, subfamily d, polypeptide 4; cytochrome P450, family 2, subfamily D, polypeptide 6; cytochrome P450, family 2, subfamily D, polypeptide 7 pseudogene 2; cytochrome P450, family 2, subfamily D, polypeptide 8 pseudogene 2; cytochrome P450, subfamily 2D, polypeptide 6; cytochrome P450, subfamily II (debrisoquine, sparteine, etc., -metabolising), polypeptide 7 pseudogene 2; cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolising), polypeptide 8 pseudogene 2; cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolizing), polypeptide 6; cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolizing)-like 1; cytochrome P450, subfamily IID, polypeptide 6; Cytochrome P450, subfamily IID3; Cytochrome P450, subfamily IID4; Cytochrome P450-CMF3; Cytochrome P450-DB1; Cytochrome P450-DB3; Cytochrome P450-DB4; Debrisoquine 4-hydroxylase; flavoprotein-linked monooxygenase; microsomal monooxygenase; nonfunctional cytochrome P450 2D6; P450 2D-29/2D-35; P450C2D; P450-CMF3; P450DB1; P450-DB1; P450-DB3; P450-DB4; xenobiotic monooxygenase
Host Species:
Rabbit
Purification Method:
Protein A
Regulatory Status:
RUO
Gene ID (Entrez):
1565
Content And Storage:
-20°C
Form:
Liquid
Applications:
Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot
Concentration:
1 μg/mL
Formulation:
PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH
Gene Accession No.:
P10635
Gene Symbols:
CYP2D6
Immunogen:
KLH conjugated synthetic peptide derived from human CYP2D6.
Quantity:
100 μL
Primary or Secondary:
Primary
Target Species:
Human
Product Type:
Antibody
Isotype:
IgG